In short. The shape of a biostimulator course: why a small number of sessions several weeks apart is the norm, and why shorter intervals add risk without adding result.

Key points

  • The defensible shape of a course is a first session, a review at about three months against standardised photographs, and then a decision about the remaining sessions made on what those photographs show.
  • A number of sessions fixed before your tissue has responded to anything is a sales figure, not a clinical plan.

Almost every question about a biostimulator course comes down to two numbers: how many sessions, and how far apart. Neither is arbitrary. The intervals exist because tissue needs time to respond to one session before the next is added, and the session count exists because the effect accumulates across the course rather than after any single appointment.

Why the intervals are not a scheduling convenience

After a session, the material is deposited and your own tissue responds over the following weeks. That response is the treatment. Adding another session before the first has been allowed to work means treating tissue that is still reacting, which is when nodules and uneven results are most likely. A plan that compresses the intervals to fit a holiday is a worse plan, not a faster one.

The practical consequence is that a course takes months of calendar time. Most plans use a small number of sessions several weeks apart, and the effect is judged as the course completes.

A plan with a review point, not a package

The defensible shape of a course is a first session, a review at about three months against standardised photographs, and then a decision about the remaining sessions made on what those photographs show. A number of sessions fixed before your tissue has responded to anything is a sales figure, not a clinical plan.

How many sessions, and what decides it

The honest answer depends on how much tissue needs support, how many areas are treated, and how you responded to the first session. Diffuse loss across the midface asks for more than a single area. Your own response is the variable no assessment can predict, which is why a first session followed by a review is better than a course sold as a block.

Spacing the course around your life

The waiting between sessions is not downtime. Tenderness and occasional bruising settle within days, there is no wound to heal, and most people return to work the same day. What the intervals ask of you is patience rather than recovery. Plan the course around a period when you can tolerate seeing no change for a few weeks.

Planning mistakes worth avoiding

  • Compressing the intervals to finish before an event, which adds nodule risk without adding effect and is the most common avoidable error.
  • Buying a fixed package of sessions before the first review, which removes the stopping rule that protects you from an unnecessary course.
  • Judging the plan after one session. A single appointment is the beginning of a course, not a result that can be assessed.

If a clinic will tell you how many sessions you need before it has seen how your tissue responds to one, that number is a price list rather than a plan. The more honest sequence is a first session, a review at about three months, and a decision made then — with the option to stop if the photographs show that the course has already given you what it can.

Related reading

Frequently asked questions

Why can the sessions not simply be done closer together?

Because tissue needs time to respond to each session before the next one is added, and stacking treatment onto tissue that has not finished responding adds risk without adding effect. Crowded intervals are a recognised contributor to nodules, which is a poor trade for finishing a few weeks earlier.

How is the number of sessions decided?

From the extent of the volume loss, the number of areas treated, how your tissue responded to the first session, and what the standardised photographs show at the review. It is set as a plan with a review point rather than as a fixed package agreed before your tissue has responded to anything.

What happens if I miss or delay a session?

Usually very little. The intervals are a minimum spacing rather than an appointment that expires, and delaying a session does not undo what the earlier ones deposited. Tell the clinic, and the remaining plan is rearranged around the new dates rather than restarted.

Risks & Limitations

  • Nodules and granulomas — firm lumps or an inflammatory reaction that can appear weeks or months after treatment and may need assessment and treatment rather than simply resolving.
  • Irreversibility: a biostimulator cannot be dissolved. An uneven or unwanted result has to be managed over time, not switched off.
  • Infection or inflammation at the injection site.
  • Asymmetry or over-correction. Over-treatment in an area that cannot be dissolved is harder to correct than under-treatment.
  • Lumpiness or irregularity in the first weeks while the material settles, which usually resolves but occasionally does not.
  • Bruising, swelling, tenderness and occasional headache after treatment.
  • A biostimulator does not lift descended tissue and does not remove fat. The effect is gradual over months, it is not permanent, and maintenance treatment is required.

When to Seek Care

  • A firm, growing or painful lump at or near an injection site, appearing weeks or months after treatment — this needs assessment even when it is not painful.
  • Redness, warmth, swelling or pus at an injection site, or fever.
  • Skin breakdown, blistering, or a dusky or mottled patch over a treated area — seek care immediately.
  • Increasing pain, or pain out of proportion to the injection.
  • Difficulty breathing, facial swelling or a widespread rash — possible severe reaction; seek emergency care immediately.

References & Further Reading

  • American Academy of Dermatology (AAD) — injectable and skin safety information
  • American Society of Plastic Surgeons (ASPS) — injectable treatment guidance
  • U.S. Food and Drug Administration (FDA) — approved injectable products and safety communications
  • National Medical Products Administration (NMPA, China) — approved product status
  • Chongqing West District Hospital — Plastic Surgery & Aesthetics Medical Center

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.